Correlation Between Emergent Biosolutions and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Neurocrine Biosciences, you can compare the effects of market volatilities on Emergent Biosolutions and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Neurocrine Biosciences.
Diversification Opportunities for Emergent Biosolutions and Neurocrine Biosciences
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Emergent and Neurocrine is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Neurocrine Biosciences
Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Neurocrine Biosciences. In addition to that, Emergent Biosolutions is 3.64 times more volatile than Neurocrine Biosciences. It trades about -0.06 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.07 per unit of volatility. If you would invest 8,190 in Neurocrine Biosciences on January 31, 2024 and sell it today you would earn a total of 5,699 from holding Neurocrine Biosciences or generate 69.58% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Emergent Biosolutions vs. Neurocrine Biosciences
Performance |
Timeline |
Emergent Biosolutions |
Neurocrine Biosciences |
Emergent Biosolutions and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Emergent Biosolutions and Neurocrine Biosciences
The main advantage of trading using opposite Emergent Biosolutions and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. PetIQ Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences |
Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |